What are the key predictions for the ICU CDSS industry? What are the major developments across segments like end-to-end clinical solutions, vendor-agnostic solutions, and EMR/EHR platforms? Explore the revenue of this sector and future prospects for digital transformation.
What is the role of scheduling solutions and logistics robots in alleviating clinician burnout? Examine the various strategies used by hospitals to retain clinical staff. Also, analyze the regional spread of solutions, potential growth directions, revenue forecasts, and more.
Take an in-depth look into key segments, such as blood pressure monitors, and identify the factors driving this sector, including increasing acceptance of remote monitoring technologies. Get a detailed overview of devices for physiological parameter tracking, diagnosis, and more.
Frost & Sullivan Institute (FSI), Frost & Sullivan’s 501(c)(3) non-profit organization dedicated to utilizing business practices to address global priorities, commends Best-in-Class Companies with Global Enlightened Growth Leadership Best Practices Recognition for 2022. Join us as we recognize some of the most committed leadership teams. These companies have adopted strategies to build upon sustained growth excellence with a moral imperative. These Companies are committed to the environment and sustainability, demonstrating best practices both internally and externally. They are moving the world in the right direction by leveraging either technology, innovation and/or strategic partnerships to make strides in innovating some of the most pressing challenges we face today to zero.
Described as the next step in the evolution of the internet and social media, Frost & Sullivan’s Research Director Kiran Kumar V. defines the metaverse as an interconnected network of virtual worlds that are shared and persistent, which will serve as a new paradigm where our digital and physical lives converge.
In this third episode of our “Future of CPG” series, we will focus on decentralized autonomous organizations (DAOs). Centralization or decentralization? This question is crucial for any player that wants to build a metaverse action plan for the next 10 years. The metaverse expansion can be accomplished in both cases. Let’s explore DAO growth opportunities together.
Schedule a dialog or email us at myfrost@frost.com to connect with an industry expert at no charge. We are taking unprecedented action to make our team available to help you cut through the media and politics to get factual one-to-one guidance for the issues and opportunities that matter most to your business.
Explore the future M&A activities among legacy EMR companies and CDI vendors
Read more Request Info
Examine the participation of top tech companies, value propositions, and applications
Read more Request Info
How can this industry increase brand awareness, reputation, revenue, and much more?
Read more Request Info
Which avenues can MedTech and health IT vendors leverage for a loyal customer base?
Read more Request Info
What are the major dynamics around product innovation and the reimbursement scenario?
Read more Request Info
Analyze the capacity expansions by major Bio-CDMOs and the recent CGT investments
Read more Request Info
Assess the industry’s instruments/platforms, consumables (assays and kits), and more
Read more Request Info
Examine the expansion of use cases and the impact of cost and portability of devices
Read more Request InfoThe adoption of cloud technology in healthcare is on the rise. Frost & Sullivan’s Global Cloud User Survey, Q4 2021 points to 43% of healthcare respondents agreeing that a cloud strategy was essential to remaining competitive, while 41% strongly agreed with the statement that the cloud is the most important part of a digital transformation strategy; 75% agreed that the cloud was crucial or extremely important for achieving healthcare business goals. Clearly, the cloud is an important technology for healthcare’s future. But how is the technology helping achieve public health goals, especially in a country like India, which is now emerging as an eager adopter of healthcare technologies?
Read more
Breast cancer has overtaken lung cancer as the most diagnosed cancer across the globe. It is also the most prevalent form of cancer, with 7.8 million women surviving the disease. The World Health Organization’s data indicates that 2.3 million women were diagnosed with breast cancer in 2020, and about 685,000 women lost their lives to this disease that year. With staggering statistics like these, it is natural that many efforts globally have focused on breast cancer for decades. Several technology solutions have emerged as a result to help tackle the challenges involved with this disease. This is an attempt to identify some of the solutions to help improve awareness of the disease and the myriad solutions available this #BreastCancerAwarenessMonth.
Read more
Breast cancer is considered a major public health concern due to high rates of morbidity and mortality. According to the World Health Organization (WHO), about 2.3 million women were diagnosed with breast cancer in 2020, and it was one of the leading causes of women’s mortality, causing 685,000 deaths globally. Compared to other types of cancer, women with breast cancer have a higher number of lost disability-adjusted life years (DALYs). Regular breast cancer screening, usually conducted using mammography, helps detect cancers at an early stage to provide on-time quality treatment with high chances of survival compared to late-stage cancers. The importance of mammography screenings has grown over time, and the equipment is now considered the gold standard for breast cancer screening.
Read more
Rising patient awareness drives technological advances and expands marketing for prenatal genetic tests globally, according to Frost & Sullivan’s recent analysis, Global Prenatal Genetic Testing Industry. Physicians’ emphasis on tests for children and parents in regular clinical consultations has further accelerated the industry’s growth. The global market for prenatal genetic testing is expected to reach $11.39 billion by 2026 from $8.08 billion in 2021, registering expansion at a compound annual growth rate (CAGR) of 7.1%.
Based on its recent analysis of the global decentralized clinical trials (DCT) industry, Frost & Sullivan has recognized leading global clinical research organization (CRO) Parexel with the 2022 Global Customer Value Leadership Award. Parexel combines in-house expertise, patient and caregiver insights, and cutting-edge technologies to plan, operationalize, and deliver DCTs for biopharmaceutical customers worldwide while ensuring the highest levels of patient safety. The company offers Phase I-IV clinical trial capabilities, integrated consulting expertise, and broad therapeutic expertise to accelerate new therapies for patients.
As we commemorate World Mental Health Day and this year’s theme, “Make mental health & well-being for all a global priority,” Frost & Sullivan joins worldwide efforts to raise awareness about the relevance of the topic. Today, we have a better chance than ever to talk about the impact of psychological health in every aspect of our life, the importance of asking for help while struggling with any issue, and the need to eliminate the stigma surrounding those issues.
Read more
